InterMed Discovery Acquires Sustainable Source for Omega-3 Fatty Acid
News Aug 21, 2009
InterMed Discovery (IMD) has announced the acquisition of microbial Omega-3 fatty acid production strains and related know-how from the University of Saarland. This microbial source has the potential to produce Omega-3 more sustainably and reliably compared to established sources.
The two fatty acids EPA and DHA are particularly important and the concentrations of both and their ratios are directly related to the utility of Omega-3 in different therapeutic settings. At present, Omega-3 fatty acids, particularly those with high levels of EPA, are derived from fish. However, with dwindling fish populations and rising demand for Omega-3 the search for more sustainable alternatives has been on.
In addition, fish is an unreliable source since the Omega-3 concentration can exhibit significant batch variation. This is also a problem with potential alternative sources such as algae, which generate mainly DHA while the yields for EPA are very low or even none at all.
The microbial strains that IMD has acquired are sustainable sources that generate reliably high yields of Omega-3 fatty acids, which significantly out-perform current sources. This source also offers a more favorable ratio between the fatty acids DHA and EPA. This is in turn expected to lead to the development of enhanced Omega-3 formulations allowing for outstanding and new product applications for the Pharma, Food and Dietary Supplement industries.
“These microbial strains offer not only a new sustainable and reliable source of Omega-3, but also give us the capability to develop products with outstanding quality at competitive pricing,“ said Bernard Becker, Managing Director of InterMed Discovery. “This new microbial source, in conjunction with our world-class technology platform, gives us the leading edge in this competitive market and further enhances the reputation of our functional ingredients business.”
IMD will lead the collaborative research and development project with the team at the University of Saarland. Financial terms were not disclosed.
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
CRISPR Editing Stops HIV Virus in Infected CellsNews
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.READ MORE
Genetics Help Make a Weed a WeedNews
A study has has found that the success of weedy and invasive plants like the Jerusalem artichoke lies in their genes. Understanding how invasive plants evolve and the genes that enable them to thrive in a new environment is key to better understanding why they are wreaking havoc on natural landscapes and food production around the world.READ MORE